Orange County NC Website
Browse       Search
<br /> <br />16 <br />Revised 9/8/2021 <br />withdrawal and termina tion of these terms. The letter must be signed by the AOR and other <br />appropriate individuals with authority. CMS will not be liable for any withdrawal close -out <br />costs that are borne by the Recipient. Recipients have three (3) days to return all unused gra nt <br />funds. <br /> <br />32. Mandatory Disclosures. Consistent with 45 CFR §75.113, applicants and r ecipients must <br />disclose in a timely manner, in writing to CMS, with a copy to the HHS Office of the <br />Inspector General (OIG), all information related to violations of federal criminal law involving <br />fraud, bribery, or gratuity violations potentially affecting the federal award. Additionally, <br />subrecipients must disclose, in a timely manner, in writing to the prime recipient (pass through <br />entity) and the HHS OIG, all information related to violations of federal criminal law <br />involving fraud, bribery, or gratuity violations potentially affecting the federal award. <br />Disclosures must be sent in writing to CMS and to the HHS OIG at the following address es: <br /> <br />U.S. Department of Health & Human Services <br />Centers for Medicare & Medicaid Services <br />Office of Acquisition and Grants Management <br />Attn: Director, Division of Grants Management, Mandatory Grant Disclos ures <br />7500 Security Blvd, Mail Stop B3-30-03 <br />Baltimore, MD 21244-1850 <br /> <br />Materials should also be scanned and emailed to your Grants Management Specialist. <br /> <br />AND <br /> <br />U.S. Department of Health & Human Services <br />Office of Inspector General <br />ATTN: Mandatory Grant Disclosures, Intake Coordinator <br />330 Independence Avenue, SW, Cohen Building <br />Room 5527 <br />Washington, DC 20201 <br /> <br />Fax: (202) 205-0604 (Include “Mandatory Grant Disclosures” in subject line) or <br />Email: MandatoryGranteeDisclosures@oig.hhs.gov <br /> <br />Failure to make required disclosures can result in any of the remedies described in 45 CFR <br />§75.371, Remedies for noncompliance, including suspension or debarment (See 2 CFR parts <br />180 & 376 and 31 U.S.C. 3321). <br /> <br />33. Remedies for noncompliance. If a non-Federal entity fails to comply with Federal statutes, <br />regulations, or the terms and conditions of a Federal award, the HHS awarding a gency or pass- <br />through entity may impose additional conditions, as described in 45 CFR §75.207, Specific <br />award conditions. If the HHS awarding agency or pass -through entity determines that <br />noncompliance cannot be remedied by imposing additional conditions, the Federal awar ding <br />agency or pass -through entity may take one or more actions as set forth in 45 CFR §75.371, <br />Remedies for noncompliance. <br /> <br />34. Suspension and Debarment Regulations. Recipient must comply with 45 CFR §75.213, <br />which states that non-federal entities and contractors are subject to the non-procurement <br />DocuSign Envelope ID: 7832B0E4-F34E-430E-A3C2-1A6A14F29307